Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
KBA-1412 by Kling Biotherapeutics for Melanoma: Likelihood of Approval
KBA-1412 is under clinical development by Kling Biotherapeutics and currently in Phase I for Melanoma. According to GlobalData, Phase I...
Data Insights
KBA-1412 by Kling Biotherapeutics for Solid Tumor: Likelihood of Approval
KBA-1412 is under clinical development by Kling Biotherapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...